Increased morbidity rates in patients with heart disease or chronic liver disease following radical gastric surgery
Background The aim of this study was to investigate possible associations between (i) comorbid disease and (ii) perioperative risk factors and morbidity following radical surgery for gastric cancer. Materials and Methods Consecutive patients (759) undergoing radical gastrectomy and D2 level lymph no...
Saved in:
Published in | Journal of surgical oncology Vol. 101; no. 3; pp. 200 - 204 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.03.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
The aim of this study was to investigate possible associations between (i) comorbid disease and (ii) perioperative risk factors and morbidity following radical surgery for gastric cancer.
Materials and Methods
Consecutive patients (759) undergoing radical gastrectomy and D2 level lymph node dissection for gastric cancer were included. Clinical data concerning patient characteristics, operative methods, and complications were collected prospectively.
Results
The morbidity rate for radical gastrectomy was 14.2% (108/759). The most significant comorbid risk factors for postoperative morbidity were heart disease [anticoagulant medication: OR = 1.5 (95% CI = 0.35–6.6, P = 0.53); history without medication: OR = 4.0 (95% CI = 1.1–14.6, P = 0.03); history with current medication: OR = 6.7 (95% CI = 1.5–29.9, P = 0.01)] and chronic liver disease [chronic hepatitis: OR = 2.4 (95% CI = 0.9–6.5, P = 0.07); liver cirrhosis class A: OR = 8.4 (95% CI = 2.8–25.3, P = 0.00); liver cirrhosis class B: OR = 9.38 (95% CI = 0.7–115.5, P = 0.08)]. The most significant perioperative risk factors for postoperative morbidity were high TNM stage and combined organ resection (P < 0.05), and there was no association between increased postoperative morbidity and well controlled hypertension, anticoagulant therapy, diabetes mellitus, pulmonary disease, tuberculosis, or thyroid disease (P > 0.05).
Conclusion
Patients with heart disease or chronic liver disease are at a higher risk of morbidity following radical surgery for gastric cancer. J. Surg. Oncol. 2010; 101:200–204. © 2010 Wiley‐Liss, Inc. |
---|---|
Bibliography: | ArticleID:JSO21467 istex:1EC754D934B689F5E70E13E3C44094A14F0E6B89 ark:/67375/WNG-7PLC0Q7B-Q ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0022-4790 1096-9098 |
DOI: | 10.1002/jso.21467 |